Medicare's plan to fix drug shortages; Caribou's encouraging CAR-T therapy results

Caribou said its off-the-shelf CAR-T therapy induced durable, complete remissions in 44% of patients with advanced B-cell lymphoma.

July 18, 2023 Check out STAT+

Sponsored By

Jenny Kane/AP STAT+ | Medicare has a new plan to address drug shortages — but it could backfire Medicare has a new proposal to pay hospitals more to stockpile essential drugs, as doctors report running low on critical chemotherapies. By John Wilkerson STAT+ | Caribou posts encouraging durability results on its off-the-shelf CAR-T therapy The new data move the treatment closer to the benchmarks set by more established, patient-specific CAR-T therapies. By Adam Feuerstein STAT+ | Three women sue cancer diagnostic firm Grail alleging harassment, retaliation In a statement, a spokesman for Grail said the company was reviewing the complaints but was "confident that the claims are without merit." By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser